Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Fruzaqla
Fruquintinib
Takeda
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 299
2023 Revenue in Millions : 15
Growth (%) : 1,900
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF